Last Updated on October 17, 2024 by The Health Master
Global pharma major Lupin Limited announced the US launch of tavaborole topical solution, 5% having received an approval from the United States Food and Drug Administration (USFDA).
The product will be manufactured at Lupin’s facility in Pithampur, India.
Tavaborole topical solution, 5%, is generic equivalent of Kerydin topical solution, 5%, of Anacor Pharmaceuticals, Inc. and is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to trichophyton rubrum or trichophyton mentagrophytes.
Tavaborole topical solution, 5% has an estimated annual sales of US$ 53 million in the US, according to IQVIA MAT May 2021.
Unichem gets tentative USFDA nod for drug to treat Diabetes
Alembic gets USFDA final nod for Erlotinib Tablets
Alembic gets USFDA nod for drug for the treatment of Depression
USFDA approves Abbott’s Stent to treat high bleeding risk patients
Zydus Cadila gets USFDA nod for drug to treat HIV infection
Alembic gets USFDA nod for Nitrofurantoin Capsules USP
Govt waives import duty on these Raw Materials and APIs
NPPA seeks details for 29 formulations from Drug Mfrs to fix…
Serum Institute to start Mfg Sputnik vaccine in September
Nutraceutical Industry: A trending Market
6 reasons: How Gel creams are different from traditional cold creams
FDA seizes fake drugs worth Rs. 50 lakh from drug dealers
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
